483
Giora Weisz MDFDA 483 - Giora Weisz MD - October 24, 2019
Record Details
An FDA inspection of Giora Weisz MD in Bronx, NY, identified a significant deviation from the investigational plan. The firm failed to adhere to protocol for scheduled laboratory assessments and did not properly follow exclusion criteria for study subjects. This indicates a lack of compliance with established clinical trial procedures.
Open in Dashboard
ID · 20c8a88f-acb4-413a-a13f-98d6f7fd4a91